GALNT2 effect on HDL-cholesterol and triglycerides levels in humans: Evidence of pleiotropy?

R Di Paola1, A Marucci1, V Trischitta2

  • 1Research Unit of Diabetes and Endocrine Diseases, IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy.

Insights

The GALNT2 enzyme influences serum lipid levels, particularly high-density lipoprotein cholesterol (HDL-C) and triglycerides (TG). Understanding GALNT2

Area of Science:

  • Biochemistry and Molecular Biology
  • Cardiovascular Research
  • Metabolic Diseases

Background:

  • The enzyme GALNT2 is implicated in regulating serum high-density lipoprotein cholesterol (HDL-C) and triglyceride (TG) levels.
  • Human studies suggest GALNT2's impact varies; extreme loss-of-function primarily affects HDL-C, while subtler changes influence TG levels.

Purpose of the Study:

  • To investigate how varying degrees of GALNT2 activity modulation affect different serum lipid fractions.
  • To elucidate the underlying molecular mechanisms responsible for GALNT2's pleiotropic effects on lipid metabolism.

Main Methods:

  • Analysis of human and animal model data linking GALNT2 activity to lipid profiles.
  • Investigating the specific molecular pathways affected by different levels of GALNT2 function.

Main Results:

  • GALNT2 plays a crucial role in shaping both HDL-C and TG serum concentrations.
  • The extent of GALNT2 alteration dictates whether HDL-C or TG levels are predominantly affected.

Conclusions:

  • GALNT2 is a key regulator of serum lipid homeostasis, with distinct effects based on its activity level.
  • Further understanding of GALNT2's mechanisms could lead to novel therapeutic strategies for atherogenic dyslipidemia.

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
722
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.8K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
56
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
60
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
51
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K